On December 13th, China Biopharmaceutical and Sinopharm Group signed a deep strategic cooperation agreement in Chengdu. The two sides will fully integrate the resources of Sinopharm Group's National University Pharmacy, SPS+professional pharmacy, and China Biopharmaceutical's rich product resources, and carry out deep cooperation in the off hospital market to jointly build a nationwide retail network and improve the convenience of patients' drug purchases. President Lian Wanyong and Vice President Wu Yijian of China National Pharmaceutical Group, CEO of China Biopharmaceutical and Chairman of CP Tianqing Xie Chengrun, Vice President of CP Tianqing Chen Hui, and others attended the signing ceremony. Liu Tianyao, General Manager of the Global Procurement and Supply Chain Service Center of China National Pharmaceutical Group, and Qi Tianze, Special Assistant to the Chairman of CP Tianqing, signed the agreement on behalf of both parties. The heads of various business units of China Biopharmaceutical and some subsidiaries of China National Pharmaceutical Group attended the signing ceremony together, and the two sides had in-depth exchanges on the cooperation content.

Lian Wanyong, President of China National Pharmaceutical Group Corporation (Sinopharm), stated that Sinopharm has abundant terminal resources and professional pharmacy management experience. China Biopharmaceutical has strong product research and development and production capabilities, and will fully integrate the advantages of both parties in the future to achieve resource complementarity and win-win cooperation. Through close cooperation across all channels and supply chains, Sinopharm Holdings will build a differentiated service and sustainable development system for China's biopharmaceutical industry. At the same time, both parties will work together to create a group of high standard and specialized pharmacies through project promotion, providing patients with more professional, convenient, and personalized pharmaceutical services. I believe that through this deep strategic cooperation and joint exploration of new models, a new chapter will be written for the development of the pharmaceutical industry.

Xie Chengrun, CEO of China Biopharmaceutical, stated that the deep alignment between China Biopharmaceutical and Sinopharm Group's strategic vision has laid a solid foundation for cooperation between the two parties. In the rapidly changing industry environment, building a healthy industrial ecosystem is crucial. By expanding cooperation areas and deepening cooperation content, both parties are expected to significantly reduce resource consumption and improve operational efficiency. China Biopharmaceuticals looks forward to partnering with Sinopharm to ensure the effective implementation of cooperative projects through setting milestones and regular phase evaluations. At the same time, the company also looks forward to exploring and incubating new cooperation opportunities with Sinopharm while focusing on its core business.

The consensus of this cooperation is the result of months of argumentation, research, and pilot testing by both parties. We believe that the partnership between China National Pharmaceutical Group and China Biopharmaceutical will achieve a perfect integration of their advantages in pharmaceutical circulation and pharmaceutical research and development production, inject new impetus into the development of the pharmaceutical industry, bring hope for more innovative treatment solutions to patients, and embark on a new journey of co creating brilliance.